Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
· manilatimes.net
Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027
Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027
NDA resubmission activities for ZYNQUISTA® in type 1 diabetes nearing completi...